Esperion completes marketing applications for bempedoic acid Seeking Alpha
Esperion Therapeutics (ESPR -1.3%) has completed the submissions of two marketing applications in the U.S., one for a bempedoic acid pill and one for a ...
February 28, 2019 at 11:48AM | "marketing" - Google News
Esperion completes marketing applications for bempedoic acid - Seeking Alpha
"marketing" - Google News
Nenhum comentário:
Postar um comentário